Key points are not available for this paper at this time.
Our study estimates SCD prevalence in France at between 19,800 and 32,400 patients in 2016, higher than previously published. This study highlights the significant disease burden associated with vaso-occlusive events.
Leleu et al. (Fri,) studied this question.